Serum Neurofilament Light Chain (NfL) and CSF Glial Fibrillary Acidic Protein (GFAP) Together Improve the Prediction of Long-Term Clinical Progression in Multiple Sclerosis

被引：0
|
作者：
Thebault, S. [1 ]
Bose, G. [2 ]
Fereshtehnejad, S. [1 ]
Bergman, H. [1 ]
Booth, R. A. [1 ]
Freedman, M. S. [1 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Brigham & Womens Hosp, Neurol, Boston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P041
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Serum neurofilament light chain (NfL)and CSF glial fibrillary acidic protein (GFAP) together improve the prediction of long-term clinical outcomes in multiple sclerosis
    Thebault, Simon
    Fereshtehnejad, Seyed Mohammad
    Bergman, Hailey
    Bose, Gauruv
    Freedman, Mark
    NEUROLOGY, 2023, 100 (17)
  • [2] The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosis
    Thebault, Simon
    Fereshtehnejad, Seyed-Mohammad
    Bergman, Hailey P.
    Breville, Gautier
    Abdoli, Mohammad
    Booth, Ronald A.
    Fadda, Giulia
    Freedman, Mark S.
    Bose, Gauruv
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) in neuromyelitis optica spectrum disorders.
    Watanabe, M.
    Nakamura, Y.
    Michalak, Z.
    Hayashi, F.
    Barro, C.
    Isobe, N.
    Matsushita, T.
    Yamasaki, R.
    Kuhle, J.
    Kira, J-I
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 78 - 79
  • [4] Serum glial fibrillary acidic protein compared with neurofilament light chain as biomarker for multiple sclerosis disease progression
    Meier, S.
    Benkert, P.
    Maceski, A.
    Schaedelin, S.
    Garcia, L. Melie
    Cagol, A.
    Barakovic, M.
    Galbusera, R.
    Subramaniam, S.
    Achtnichts, L.
    Lalive, P. H.
    Bridel, C.
    Muller, S.
    Pot, C.
    Salmen, A.
    Disanto, G.
    Zecca, C.
    Orleth, A.
    Khalil, M.
    Yaldizli, O.
    Oechtering, J.
    Battaglini, M.
    Kappos, L.
    Derfuss, T.
    Leppert, D.
    Gobbi, C.
    Granziera, C.
    Willemse, E. A. J.
    Kuhle, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 122 - 123
  • [5] Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression
    Meier, Stephanie
    Benkert, Pascal
    Maceski, Aleksandra Maleska
    Schaedelin, Sabine
    Oechtering, Johanna
    Melie-Garcia, Lester
    Cagol, Alessandro
    Barakovic, Muhamed
    Galbusera, Riccardo
    Achtnichts, Lutz
    Lalive, Patrice H.
    Bridel, Claire
    Mueller, Stefanie
    Pot, Caroline
    Salmen, Anke
    Disanto, Giulio
    Zecca, Chiara
    Abdelhak, Ahmed
    Barro, Christian
    Thebault, Simon
    D'Souza, Marcus
    Derfuss, Tobias
    Orleth, Annette
    Khalil, Michael
    Yaldizli, Ozguer
    Hermesdorf, Marco
    Wiendl, Heinz
    Piehl, Fredrik
    Fischer, Urs
    Kappos, Ludwig
    Gobbi, Claudio
    Granziera, Cristina
    Leppert, David
    Willemse, Eline A. J.
    Kuhle, Jens
    NEUROLOGY, 2023, 100 (17)
  • [6] Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
    Meier, Stephanie
    Willemse, Eline A. J.
    Schaedelin, Sabine
    Oechtering, Johanna
    Lorscheider, Johannes
    Melie-Garcia, Lester
    Cagol, Alessandro
    Barakovic, Muhamed
    Galbusera, Riccardo
    Subramaniam, Suvitha
    Barro, Christian
    Abdelhak, Ahmed
    Thebault, Simon
    Achtnichts, Lutz
    Lalive, Patrice
    Muller, Stefanie
    Pot, Caroline
    Salmen, Anke
    Disanto, Giulio
    Zecca, Chiara
    D'Souza, Marcus
    Orleth, Annette
    Khalil, Michael
    Buchmann, Arabella
    Du Pasquier, Renaud
    Yaldizli, Ozgur
    Derfuss, Tobias
    Berger, Klaus
    Hermesdorf, Marco
    Wiendl, Heinz
    Piehl, Fredrik
    Battaglini, Marco
    Fischer, Urs
    Kappos, Ludwig
    Gobbi, Claudio
    Granziera, Cristina
    Bridel, Claire
    Leppert, David
    Maceski, Aleksandra Maleska
    Benkert, Pascal
    Kuhle, Jens
    JAMA NEUROLOGY, 2023, 80 (03) : 287 - 297
  • [7] Combining levels of serum neurofilament light chain with CSF glial fibrillary acidic protein improves the prediction of long-termclinical outcomes in multiple sclerosis
    Thebault, S.
    Fereshtehnejad, S. -M.
    Bose, G.
    Abdoli, M.
    Freedman, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 960 - 960
  • [8] Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) as potential biomarkers for disease activity and disability in neuromyelitis optica spectrum disorders and multiple sclerosis
    Watanabe, Mitsuru
    Nakamura, Yuri
    Michalak, Zuzanna
    Hayashi, Fumie
    Barro, Christian
    Isobe, Noriko
    Matsushita, Takuya
    Yamasaki, Ryo
    Kuhle, Jens
    Kira, Jun-ichi
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 438 - 439
  • [9] The role of Serum Neurofilament Light Chain (NfL) and Glial Fribrillary Acidic Protein (GFAP) in predicting cognitive impairment in patients with Multiple Sclerosis
    Santos, Irina
    Duarte, Leonor
    Machado, Rita Brito
    Fernandes, Catarina
    Correia, Ines
    Macario, Maria do Carmo
    Nunes, Carla
    Jacinto Santana, Maria Isabel
    Baldeiras, Ines
    Batista, Sonia
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 162 - 162
  • [10] Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis
    Giarraputo, James
    Giamberardino, Stephanie
    Arvai, Stephanie
    Maichle, Sarah
    Eckstein, Christopher
    Newby, L. Kristin
    Gregory, Simon
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 354
12345